[DOI] [PubMed] [Google Scholar] 75.Pi-Sunyer X., Astrup A., Fujioka K., Greenway F., Halpern A., Krempf M., Lau D.C.W., Roux C.W., Ortiz R.V., Jensen C.B., et al
Unprecedented demand for the potent new weight-loss drugs targeting the GLP-1 hormone led analysts to project a market of $150 billion - or even $200 billion - by the early 2030s
Within laboratory settings, it is frequently examined for its potential involvement in tissue regeneration processes, inflammatory response modulation, and recovery mechanisms affecting muscles, tendons, ligaments, and gastrointestinal tissues
Promotes Satiety As an incretin hormone 11 , GLP-1 promotes satiety through both the central nervous system (CNS), which involves the brain and spinal cord, and peripheral pathways, which refer to processes or parts outside of the CNS
Our team has seen researchers debate this endlessly
This selectivity results to GH increases without affecting other hormones